Comparison of four methods for the determination of platelet function in whole blood in cardiac surgery

Thrombosis Research

Volumn 89, Issue 6, 1998, Pages 295-301

  Dietrich, Gerald Volker ^a   Schueck, Reinhard ^a   Menges, Thilo ^a   Kiesenbauer, Nicole Patricia ^a   Fruehauf, Ann Catherine ^a   Marquardt, Inka ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CLOTTING PARAMETERS; CORONARY ARTERY BYPASS GRAFT; HEMOSTASIS; IMPEDANCE AGGREGOMETRY; IN VITRO BLEEDING TEST; INTERMETHOD COMPARISON; PLATELET FUNCTION PAF TEST; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY;

BLEEDING TIME; BLOOD PLATELETS; PLATELET AGGREGATION; PLATELET COUNT; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; THORACIC SURGICAL PROCEDURES;

EID: 0032520740     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00020-6     Document Type: Article

References (35)

1. Fassin W., Himpe D., Alexander J.P., Borms S., Theunissen W., Muylaert P., Van Cauwelaert P. Predictive value of coagulation testing in cardiopulmonary bypass surgery. Acta Anaesthesiol Belg. 42:1991;191-198.
2. Holloway D.S., Summaria L., Sandesara J., Vagher J.P., Alexander J.C., Caprini J.A. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 59:1988;62-67.
3. Spannagl M., Dooijewaard G., Dietrich W., Kluft C. Protection of single chain urokinase type plasminogen activator (scu PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass. Thromb Haemost. 73:1995;825-828.
4. Lu H., Du Buit C., Soria J., Touchot B., Chollet B., Commin P.L., Conseiller C., Echter E., Soria C. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy. Thromb Haemost. 72:1994;438-443.
5. Orchard M.A., Goodchild C.S., Prentice C.R., Davies J.A., Benoit S.E., Creighton-Kemsford L.J., Gaffney P.J., Michelson A.D. Aprotinin reduces cardiopulmonary bypass induced blood loss and inhibits fibrinolysis without influencing platelets. Br J Haematol. 85:1993;533-541.
6. Hartert H.H. Resonance thrombography, theoretical and practical elements. Biorheology. 18:1981;693-701.
7. Tuman K.J., McCarthy R.J., Djuric M., Rizzo V., Ivankovich A.D. Evaluation of coagulation during cardiopulmonary bypass with a heparinase modified thromboelastographic assay. J Cardiothorac Vasc Anesth. 8:1994;144-149.
8. Cardinal D.L., Flower R.J. The electronic aggregometer. A novel device for assessing platelet behaviour in blood J Pharmacol Methods. 3:1980;135-158.
9. Mammen E.F., Alshameeri R.S., Comp P.C. Preliminary data from a field trial of the PFA 100 system. Semin Thromb Hemost. 21(Suppl 2):1995;113-121.
10. Kundu S.K., Heilmann E.J., Sio R., Garcia C., Davidson R.M., Ostgaard R.A. Description of an in vitro platelet function analyser PFA 100. Sem Thromb Hemostas. 21(Suppl 2):1995;106-112.
11. Kratzer M.A., Born G.V. Simulation of primary haemostasis in vitro. Haemostasis. 15:1985;357-362.
12. Dietrich G.V., Kretschmer V., Weber D., Haupt W., Langen B., Huss B. Variables influencing the Thrombostat 4000. Recommended standardization Semin Thromb Hemost. 21(Suppl 2):1995;11-19.
13. Despotis G.J., Levine V., Filos K.S., Santoro S.A., Joist J.H., Spitznagel E., Goodnough L.T. Evaluation of a new point-of-care test that measures PAF-mediated accelaration of coagulation in cardiac surgical patients. Anaesthesiology. 85:1996;1311-1323.
14. Hattersley P.G. Activated coagulation time of whole blood. JAMA. 196:1966;436-472.
15. Despotis G.J., Joist J.H., Hogue C.W. Jr., Alsoufiev A., Kater K., Goodnough L.T., Santoro S.A., Spitznagel E., Rosenblum M., Lappas D.G. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 110:1995;46-54.
16. Davies G.G., Wells D.G., Mabee T.M., Sadler R., Melling N.J. Platelet leukocyte plasmapheresis attenuates the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg. 53:1992;274-277.
17. Christenson J.T., Reuse J., Badel P., Nowicki B., Simonet F., Schmutziger M. Autologous platelet sequestration in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 10:1996;1083-1089.
18. Hackmann T., Naiman S.C. Con, desmopressin is not of value in the treatment of post cardiopulmonary bypass bleeding. J Cardiothorac Vasc Anesth. 5:1991;290-293.
19. de Prost D., Barbier Boehm G., Hazebroucq J., Ibrahim H., Bielsky M.C., Hvass U., Lacombe C., Francais J.L., Desmonts J.M. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thromb Haemost. 68:1992;106-110.
20. Reynolds L.M., Nicolson S.C., Jobes D.R., Steven J.M., Norwood W.I., McGonigle M.E., Manno C.S. Desmopressin does not decrease bleeding after cardiac operation in young children. J Thorac Cardiovasc Surg. 106:1993;954-958.
21. Menys V.C., Belcher P.R., Noble M.I., Evans R.D., Drossos G.E., Pillai R., Westaby S. Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting respectively, is specifically impaired following cardiopulmonary bypass in man. Thromb Haemost. 72:1994;511-518.
22. Irani M.S., Izzat N.N., Jones J.W. Platelet function, coagulation tests, and cardiopulmonary bypass, lack of correlation between pre operative and intra operative whole blood lumiaggregometry and peri operative blood loss in patients receiving autologous platelet rich plasma. Blood Coagul Fibrinolysis. 6:1995;428-432.
23. Gelb A.B., Roth R.I., Levin J., London M.J., Noall R.A., Hauck W.W., Cloutier M., Verrier E., Mangano D.T. Changes in blood coagulation during and following cardiopulmonary bypass, lack of correlation with clinical bleeding. Am J Clin Pathol. 106:1996;87-99.
24. Gravlee G.P., Arora S., Lavender S.W., Mills S.A., Hudspeth A.S., Cordell A.R., James R.L., Brockschmidt J.K., Stuart J.J. Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg. 58:1994;216-221.
25. Ereth M.H., Nuttall C.A., Klindworth J.T., MacVeigh I., Santrach P.I., Orszulak T.A., Harmsen W.S., Oliver W.C. Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? Anesth Analg. 85:1997;259-264.
26. Tabuchi N., Tigchelaar I., van Oeveren W. Shear induced pathway of platelet function in cardiac surgery. Semin Thromb Hemost. 21(Suppl 2):1995;66-70.
27. Spiess B.D. The contribution of fibrinolysis to postbypass bleeding. J Cardiothorac Vasc Anesth. 5(Suppl 1):1991;13-17.
28. Campbell F.W. The contribution of platelet dysfunction to postbypass bleeding. J Cardiothorac Vasc Anesth. 5(Suppl 1):1991;8-12.
29. Spiess B.D., Gillies B.S., Chandler W., Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 9:1995;168-173.
30. Essell J.H., Martin T.J., Salinas J., Thompson J.M., Smith V.C. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 7:1993;410-415.
31. Martin P., Horkay F., Rajah S.M., Walker D.R. Monitoring of coagulation status using thrombelastography during paediatric open heart surgery. Int J Clin Monit Comput. 8:1991;183-187.
32. Ray M.J., Marsh N.A., Hawson G.A. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinolysis. 5:1994;679-685.
33. Karski J.M., Teasdale S.J., Norman P., Carroll J., VanKessel K., Wong P., Glynn M.F. Prevention of bleeding after cardiopulmonary bypass with high dose tranexamic acid. Double blind, randomized clinical trial. J Thorac Cardiovasc Surg. 110:1995;835-842.
34. Casas J.I., Zuazu Jausoro I., Mateo J., Oliver A., Litvan H., Muniz Diaz E., Aris A., Caralps J.M., Fontcuberta J. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double blind placebo controlled study. J Thorac Cardiovasc Surg. 110:1995;1107-1117.
35. Rocha E., Hidalgo F., Llorens R., Melero J.M., Arroyo J.L., Paramo J.A. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation. 90:1994;921-927.